<prompt> A methotrexate intolerant psoriasis patient has been prescribed an alternate disease modifying drug DMARD that resulted in liver dysfunction combined with skin rashes and bone marrow suppression of RBCs platelets. The most probable drug isAnakinraLeflunomideAbataceptSulfasalazine  <response>: Answer: b Leflunomide Abatacept is associated with infections due to inhibition of normal T-cell activity. Sulfasalazine causes agranulocytosis and hepatitis along with rashes. Leflunomide causes skin rashes and bone marrow suppression of RBCs platelets. Anakinra therapy may lead to neutropenia but not bone marrow suppression. 